Qingfeng Pharmaceutical's Entecavir passed the consistency evaluation

China Jiangxi Net News On May 21, the reporter learned from the Jiangxi Food and Drug Administration that the two formulations of Entecavir (trade name: Weiliqing) dispersible tablets and capsules of Jiangxi Qingfeng Pharmaceutical Co., Ltd. have obtained the approval for the consistency evaluation of efficacy evaluation from CDE. Weiliqing became the first batch of domestic Entecavir manufacturers to pass the consistency evaluation. In a sense, this is of great strategic significance for the promotion of consistency evaluation work in our province.